BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$8.15 USD
+0.19 (2.39%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $8.16 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, BioCryst Pharmaceuticals (BCRX) reported earnings of -$0.06 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 68.42%. Look out for BCRX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 63.16%.
Earnings History
Price & Consensus
Zacks News for BCRX
BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services